You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,335,502


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,335,502 protect, and when does it expire?

Patent 10,335,502 protects LUMASON and is included in one NDA.

This patent has twelve patent family members in ten countries.

Summary for Patent: 10,335,502
Title:Freeze-dried formulation for gas-filled microvesicles
Abstract: A freeze-dried powder composition comprising a phospholipid and a polyethylene glycol, said polyethylene glycol having a percentage of folded polymeric chains of 40% or higher. The composition is suitable for preparing gas-filled microvesicles.
Inventor(s): Lassus; Anne (Veyrier, CH), Gorgerat; Stephane (Essertines-sur-Rolle, CH), Yan; Feng (Grand Lancy, CH), Guillot; Christian (Beaumont, FR), Brochot; Jean (Cruseilles, FR)
Assignee: Bracco Suisse SA (Manno, CH)
Application Number:16/260,894
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,335,502

Introduction

When navigating the complex world of patents, understanding the scope and claims of a particular patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 10,335,502, providing a comprehensive analysis of its scope, claims, and the broader patent landscape.

What is a Patent?

A patent is a form of intellectual property that grants the patent holder the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application. The U.S. Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks[2].

The Importance of Patent Claims

Patent claims are the heart of a patent, defining the scope of protection granted to the inventor. They must be clear, concise, and supported by the patent's description. The claims determine what is considered an infringement of the patent and are often the focal point of patent litigation[3].

United States Patent 10,335,502: Overview

To analyze the scope and claims of United States Patent 10,335,502, one must first identify the patent's title, inventors, assignees, and the date it was granted. Here is a general outline:

  • Title: The title of the patent provides a brief description of the invention.
  • Inventors: The individuals who created the invention.
  • Assignees: The entities to which the patent has been assigned.
  • Grant Date: The date when the patent was officially granted.

Analyzing the Patent Claims

Claim Structure

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims.

Claim Language

The language used in the claims is critical. It must be precise and avoid ambiguity to ensure that the scope of the invention is clearly defined. Here is an example of how to analyze a claim:

Claim 1: A method for [brief description of the method], comprising:
    - Step 1: [first step of the method];
    - Step 2: [second step of the method];
    - Step 3: [third step of the method].

Claim Scope

The scope of the claims determines what is protected by the patent. It is essential to understand what is included and excluded from the protection. For instance, if a claim specifies a particular material or process, any variation that does not use that material or process may not be considered an infringement.

Patent Landscape and Prior Art

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This tool is invaluable for understanding the global patent landscape and identifying prior art that may affect the validity of the patent[1].

Common Citation Document (CCD)

The Common Citation Document (CCD) consolidates prior art citations from multiple patent offices, enabling a comprehensive view of the prior art landscape for a specific invention. This helps in assessing the novelty and non-obviousness of the patented invention[1].

Searching and Analyzing Patents

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching existing patents and published patent applications. It provides enhanced access to prior art and improves the overall patent searching process[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be beneficial for conducting thorough searches and analyses[1].

Legal Considerations and Litigation

Obviousness-Type Double Patenting (ODP)

ODP is a legal doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to adjustments like Patent Term Adjustment (PTA)[4].

Terminal Disclaimers

Terminal disclaimers are used to overcome ODP rejections by disclaiming the term of the later patent that extends beyond the term of the earlier patent. This ensures that the later patent does not extend the overall term of protection[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to handle lower-stakes patent disputes more efficiently. This could impact how patent holders and alleged infringers navigate legal challenges related to patent claims[5].

Key Takeaways

  • Patent Claims: The claims are the most critical part of a patent, defining the scope of protection.
  • Patent Landscape: Understanding the global patent landscape through tools like Global Dossier and CCD is essential for assessing the validity and scope of a patent.
  • Legal Considerations: ODP and terminal disclaimers are important legal concepts that can affect the term and validity of a patent.
  • Search Tools: Utilizing resources like the Patent Public Search and PTRCs can enhance the accuracy and thoroughness of patent searches.

FAQs

Q: What is the purpose of patent claims in a U.S. patent?

A: Patent claims define the scope of protection granted to the inventor, determining what is considered an infringement of the patent.

Q: How can I search for prior art related to a specific patent?

A: You can use the USPTO's Patent Public Search tool, Global Dossier, and the Common Citation Document (CCD) to search for prior art.

Q: What is Obviousness-Type Double Patenting (ODP)?

A: ODP is a legal doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term.

Q: What is the role of terminal disclaimers in patent law?

A: Terminal disclaimers are used to overcome ODP rejections by disclaiming the term of the later patent that extends beyond the term of the earlier patent.

Q: Are there plans for a small claims patent court in the U.S.?

A: Yes, there have been studies and discussions on the feasibility of a small claims patent court to handle lower-stakes patent disputes more efficiently.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. In re Cellect - United States Court of Appeals for the Federal Circuit: https://cafc.uscourts.gov/opinions-orders/22-1293.OPINION.8-28-2023_2181381.pdf
  5. U.S. Patent Small Claims Court - ACUS: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,335,502

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes 10,335,502 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,335,502

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2019298652 ⤷  Subscribe
Brazil 112020022883 ⤷  Subscribe
Canada 3098380 ⤷  Subscribe
China 112165959 ⤷  Subscribe
European Patent Office 3817777 ⤷  Subscribe
Japan 2021529730 ⤷  Subscribe
Japan 7128299 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.